Pluripotency not required

In a striking demonstration of cellular flexibility, scientists have created functioning neurons from fibroblasts, without going through an intermediate pluripotent stage, according to a study published online this week in Nature. Mouse cingulate cortex neuronsImage: Wikimedia commons"It's really exciting," said molecular geneticist Mathias Treier of the linkurl:European Molecular Biology Laboratory;http://www.embl.de/index.php and the linkurl:University of Cologne in Germany,;http://www.presso

By Jef Akst | January 27, 2010

Mouse cingulate cortex neurons
Image: Wikimedia commons

"It's really exciting," said molecular geneticist Mathias Treier of the linkurl:European Molecular Biology Laboratory;http://www.embl.de/index.php and the linkurl:University of Cologne in Germany,;http://www.pressoffice.uni-koeln.de/ who was not involved in the research. "It shows that cells can switch their fate" without going through the pluripotent state, avoiding the potential for tumor formation. "[In] the future, with the right cocktail mix, this [might be] possible for other tissues and organs," he added. Inspired by Shinya Yamanaka's discovery of four transcription factors that could induce a differentiated cell to regress to a pluripotent state, which could then be redifferentiated into another adult cell type, stem cell biologist linkurl:Marius Wernig;https://med.stanford.edu/profiles/frdActionServlet?choiceId=facProfile&fid=10445 of Stanford University School of Medicine wondered if there might be a shortcut. Rather than going backward to go forward, he wondered, "can we turn a skin fibroblast directly into a neuron?" To answer this question, Wernig and his colleagues injected mouse embryonic fibroblasts (MEFs) with lentiviruses containing 19 genes that are expressed in neural tissues. Sure enough, 32 days later, the MEFs displayed typical neuronal morphologies. By testing various 5-gene and 3-gene sets of the 19 original factors, the researchers narrowed the field down to just three genes -- Ascl1, Brn2, and Myt1l -- that could convert not only MEFs to neurons, but postnatal fibroblasts as well. This is not the first example of conversion from one adult cell type to another. In 2008, for example, scientists successfully linkurl:converted mature pancreatic exocrine cells into cells resembling β-cells;http://www.nature.com/nature/journal/v455/n7213/full/nature07314.html in adult mice. More recently, linkurl:a study;http://www.the-scientist.com/blog/display/56212/ reported that the loss of a single gene, Foxl2, induced the conversion of ovary into testis in adult mice. These studies support the idea that a "pluripotent stage may not be essential for the transdifferentation between terminally differentiated cells," molecular biologist Xiangru Xu of linkurl:Yale University,;http://www.yale.edu/ who did not participate in the research, wrote in an email to The Scientist. Several studies have also converted a variety of cell types into neuron-like cells. The new report, however, is the first to create fully functional neurons -- capable of generating action potentials and forming synaptic contacts with other neurons -- from another somatic lineage, Wernig said. "When you grow [these induced neuronal (iN) cells] on a preexisting neuronal culture, they are able to functionally integrate with this preexisting neuronal network," he said. "Those are true derived neurons." A major advantage to skipping the pluripotent stage is the avoidance of tumor formation, Wernig said. Because pluripotent cells are highly proliferative, "trace amounts of these cells in the graft can explode after you transfer these cells into the brain and form a specific type of tumor called [a] teratoma," he explained. "In contrast, these factors [used to form neurons] are really inducing the cells to stop cell division. They're almost anticancer genes." The disadvantage to this property of the iN cells, however, is the inability to expand them in culture, Treier said. While the pluripotent state allows for the production of large numbers of cells, with this method it's "only what you get out of a patient [that] you can convert," he said. "There's really a one to one conversion." Thus, despite the fact that the researchers achieved nearly 20% efficiency in the conversion -- well above the 0.1% or 0.01% efficiency associated with inducing pluripotency -- generating enough tissue to be useful in a therapy is unlikely, said linkurl:Sheng Ding;http://www.scripps.edu/chem/ding/ of the Scripps Research Institute in La Jolla, Calif, who did not participate in the research. "That's going to be the challenge to [using] this type of technique in the future." Furthermore, to induce the cellular change the researchers are still using genetic manipulation, a method that is inherently risky. Even without using oncogenes, inserting factors into the genome can be potentially harmful if, for example, the manipulation activates a native oncogene or disrupts the function of a tumor suppressor gene. "You have to be very careful in terms of those genetic manipulations in cells," Ding said. This problem can be overcome by replacing the genetic factors with nongenetic manipulations, Wernig pointed out, such as protein transduction, nonintegrating lentiviruses, or plasmids. But for now, he added, "a very attractive application" of this method could be the development of specific disease models. "It's not only the neurodegenerative diseases, like Parkinson's Disease," he said, "but also diseases which affect the neuronal activity of the brain, such as depression or schizophrenia or even autistic disorders." "This is very exciting work and likely the beginning of a wave of experiments growing out of the Yamanaka breakthrough," stem cell biologist linkurl:George Daley;http://daley.med.harvard.edu/ of the Harvard Stem Cell Institute and Children's Hospital Boston wrote in an email to The Scientist. "This is only the tip of the iceberg," Treier agreed. "I think we will see many more examples in the near future."
**__Related stories:__***linkurl:One gene keeps ovaries female;http://www.the-scientist.com/blog/display/56212/
[10th December 2009]*linkurl:Differentiating Hope from Embryonic Stem Cells;http://www.the-scientist.com/article/display/14321/
[15th December 2003]*linkurl:Short cut to neuron differentiation;http://www.the-scientist.com/article/display/20596/
[13th August 2002]

Comments

HENRY CHANG

Posts: 20

January 27, 2010

Instead of working with cells, I envision just the factors being injected into areas of brain damage or spine injury. Great work.

Shi Liu

Posts: 12

January 30, 2010

From the very beginning I have questioned the claim of reprogramming any adult somatic cell into an induced pluripotent stem (iPS) cell that is indistinguishable from embryonic stem (ES) cell and can be safely used for regenerative medicine. I concluded that iPS cells are incorrectly programmed stem cells or man-made cancer cells that are distinct from ES cells. My publications can be found at http://im1.biz/iPS.htm . The following is just a few titles from my many anti-iPS publications:\n\nAre iPS cells really indistinguishable from ES cells? Logical Biol.7: 66-68, 2007\n \nIPS Cells Are Man-Made Cancer Cells\n Logical Biol.8: 16-18, 2008\n \nDistinguishing Cancerous iPSCs from ESCs\n Top Watch 4(1):20-23, 2009\n \nUnderstanding the Nature and Risk of Incorrectly Programmed Stem Cells (iPSCs)\n Logical Biology 9 (1):52-60, 2009\n \nRe-Learn the Polywater Lesson for iPS Cells\n Top Watch 3:7-8, 2008\n \niPS Cells and Pseudoscience: a Huge Detour in Stem Cell Research\n Top Watch 3:9-11, 2008\n \nWhy Do We Need "Fully Pluripotent" iPS Cells?\n Top Watch 4(2):29-30, 2009\n \nTowards a Balanced View on iPS Cells\n Logical Biol.8: 32-38, 2008\n\niPS Cells: A More Critical Review\n Stem Cells and Dev. 17:391-397, 2008\n \n5 Reasons to Get off the iPS ?Airplane?\n Logical Biol.8: 42-46, 2008\n\nIn my view, iPS research represents a huge detour in stem cell research because it is a waste of time and money to create pluripotent stem cells and then differentiate them into other cells. Now my view is somehow verified or supported by this new study. Then where will the iPS cell research move to?\n